<!-- canonical: https://www.trendhunter.com/trends/ug-supports-precure-dataset -->
<!-- robots: noindex -->

# Million-Sample Multi-Omics Platforms
Ultima Genomics Supports Precure’s Large-Scale Dataset

By Mursal Rahman | Written with AI assistance | Published 2026-09-22 | Tech
Source: Trend Hunter, https://www.trendhunter.com/trends/ug-supports-precure-dataset
References: [prnewswire](https://www.prnewswire.com/news-releases/ultima-genomics-selected-to-generate-one-million-sample-world-leading-multi-omic-biomedical-dataset-for-aiml-precure-llc-initiative-302885572.html)

![Million-Sample Multi-Omics Platforms](https://cdn.trendhunterstatic.com/thumbs/636/ug-supports-precure-dataset.jpeg)

Ultima Genomics is supporting one of the largest million-sample multi-omics platforms through Precure, an initiative led by Mayo Clinic in partnership with Thermo Fisher Scientific. Precure will integrate [whole-genome sequencing](https://www.trendhunter.com/trends/illumina-inc), [proteomic information](https://www.trendhunter.com/trends/protein-spectrometry-platform) and longitudinal clinical data from one million biospecimens to identify biological signals that may appear before disease symptoms. Helix will generate sequencing data using Ultima’s UG200 platform, which can produce up to 60,000 whole genomes annually. AI and large-scale analytics will help researchers identify patterns across the combined datasets.

The project demonstrates how lower-cost, high-throughput sequencing can make population-scale biomedical research more practical. For Ultima Genomics, selection for the initiative validates the UG200’s potential for large research programs and strengthens its position in genomic infrastructure. The resulting dataset could also support researchers developing new diagnostics and therapeutics while creating opportunities for broader [AI-driven precision medicine](https://www.trendhunter.com/trends/uniqgene-ai) applications.

Image Credit: Ultima Genomics

## Trend Insights (Trend Hunter)

- Score: 5.8/10
- Popularity: 31% | Activity: 52% | Freshness: 90%
- Audience gender: 50% men, 50% women
- Primary generations: Millennial, Gen X
- Top markets: North America

## Categories

[Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [Science](https://www.trendhunter.com/science)

## Key Themes

### Key Themes Behind This Trend

- **Population-scale Multi-omics:** Massive integrated datasets combining genomics, proteomics and clinical records create new pathways for earlier disease detection and preventive care models.
- **Low-cost Genome Sequencing:** Declining sequencing costs and higher throughput enable research programs to scale from niche cohorts to million-sample biomedical platforms.
- **AI-driven Precision Medicine:** Advanced analytics applied to longitudinal biological data reveal pre-symptomatic patterns that can reshape diagnostics, therapeutics and risk prediction.

### Where This Applies

- **Genomics:** High-capacity sequencing infrastructure supports broader adoption of whole-genome analysis across clinical research and population health initiatives.
- **Biotechnology:** Large multi-omics repositories provide a foundation for discovering biomarkers, validating drug targets and accelerating therapy development.
- **Healthcare Analytics:** AI-enabled interpretation of complex patient datasets expands the role of predictive insights in personalized medicine and preventive healthcare.

## Related on Trend Hunter

- [Genetic Data AI-Training Initiatives](https://www.trendhunter.com/trends/trillion-gene-atlas.md)
- [Automated Molecular Diagnostic Systems](https://www.trendhunter.com/trends/genhome-array.md)
- [Reciprocal Clinical Trials](https://www.trendhunter.com/trends/massive-bio.md)
- [Seamless Oncology Test Integrations](https://www.trendhunter.com/trends/precision-oncology.md)
- [AI Drug Platforms](https://www.trendhunter.com/trends/insilico-medicine-mmai.md)
- [Functional Genomic Data Projects](https://www.trendhunter.com/trends/ochre-bio.md)
- [Microbial Molecule Discovery Platforms](https://www.trendhunter.com/trends/generare.md)
- [Whole Genome Interpretation Services](https://www.trendhunter.com/trends/whole-genome-interpretation.md)
